Assignee
BERGGREN PER-OLOF
SE·5 granted patents·5 pending applications·36 citations·filing 2004–2016
Top patents by PatentIndex Score
10 records- 0193US8084439B2Methods for identifying compounds for the treatment of type 1 diabetesBERGGREN PER-OLOF·Filed 2010·Granted Dec 27, 2011·16 cites·12 claims
- 0291US8507444B2ApoIII and the treatment and diagnosis of diabetesBERGGREN PER-OLOF·Filed 2011·Granted Aug 13, 2013·11 cites·4 claims
- 0386US8557513B2Methods for treating and/or limiting development of diabetesBERGGREN PER-OLOF·Filed 2012·Granted Oct 15, 2013·4 cites·10 claims
- 0471US8466185B2Methods and assays for detecting and treating hypoglycemiaBERGGREN PER-OLOF·Filed 2009·Granted Jun 18, 2013·3 cites·4 claims
- 0570US9062306B2Methods for identifying compounds for treating type 1 diabetesBERGGREN PER-OLOF·Filed 2004·Granted Jun 23, 2015·2 cites·3 claims
- 0651US2013217738A1Methods and Assays for Detecting and Treating HypoglycemiaBERGGREN PER-OLOF·Filed 2013·Application pending·0 cites
- 0750US2011287029A1Inhibition of the beta3 subunit of l-type ca2+ channelsBERGGREN PER-OLOF·Filed 2011·Application pending·0 cites
- 0846US2011318325A1Inositol Pyrophosphates Determine Exocytotic CapacityBERGGREN PER-OLOF·Filed 2011·Application pending·0 cites
- 0942US2017035793A1Use of P2X Purinergic Receptor Agonists to Enhance Insulin Secretion In Pancreatic Beta CellsBERGGREN PER-OLOF·Filed 2016·Application pending·0 cites
- 1042US2013053338A1Use of P2X Purinergic Receptor Agonists to Enhance Insulin Secretion in Pancreatic Beta CellsBERGGREN PER-OLOF·Filed 2011·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →